Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02945670 · ClinicalTrials.gov registry record

Using Focus Group to Explore Cultural Acceptability of Contraception

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
64
Enrollment target

NCT02945670 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 64 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02945670 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
64 participants
Enrollment target

Study Summary

The purpose of this study is to learn what women of childbearing age think of Long Acting Reversible Contraception. A variety of myths regarding LARCs have been described in the literature. This study is designed to asses women's cultural belief's regarding LARCs. Investigators are looking to collect information from women in general, rather than solely who are seeking contraception. Investigators will be recruiting women ages 18-45 years from seven family health centers affiliated with UPMC. Participants will be asked to a attend a 60-90 minutes focus group session. During the session the facilitator will try to engage participants in a discussion about contraception in general. They will also be asked to complete a short demographic survey of 8-12 questions. Data from focus groups will be assessed for recurring themes which will be used to create a cultural survey instrument that will be used in the second phase of the study.

Interventions

  • BEHAVIORAL Focus Group

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2017-01-02
Est. Completion 2017-03-30

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02945670

The ClinicalTrials.gov registry entry for NCT02945670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Focus Group is the first listed.

NCT02945670 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02945670 about?

NCT02945670 is a clinical study titled "Using Focus Group to Explore Cultural Acceptability of Contraception". The purpose of this study is to learn what women of childbearing age think of Long Acting Reversible Contraception. A variety of myths regarding LARCs have been described in the literature. This study is designed to asses women's cultural belief's regarding LARCs. Investigators are looking to collec...

What is the current status of trial NCT02945670?

This trial is currently completed. The enrollment target is 64 participants. The study started on 2017-01-02. Estimated completion is 2017-03-30.

What interventions are being tested in trial NCT02945670?

The interventions under investigation include: Focus Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02945670?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.